elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q36303459-5F5EE86B-80F7-48E7-8E30-69B2034ABA8A
Q36303459-5F5EE86B-80F7-48E7-8E30-69B2034ABA8A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36303459-5F5EE86B-80F7-48E7-8E30-69B2034ABA8A
A practical guide about biosimilar data for health care providers treating inflammatory diseases
P2860
Q36303459-5F5EE86B-80F7-48E7-8E30-69B2034ABA8A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36303459-5F5EE86B-80F7-48E7-8E30-69B2034ABA8A
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b920d48f2f7778d002507d8ba2b7e4ec3a4d4b91
P2860
Switching from Remicade® to Remsima® is well Tolerated and Feasible: A Prospective, Open-label Study.